Edwards Lifesciences Corp (EW) financials

Edwards Lifesciences Corp (EW) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Edwards Lifesciences Corp reported revenue of $6.07B, up 11.5% year over year, net income of $1.07B, diluted EPS of $1.83 and free cash flow of $1.33B.

Revenue (fiscal 2025)

$6.07B

Revenue growth (fiscal 2025)

11.5%

Net income (fiscal 2025)

$1.07B

Diluted EPS (fiscal 2025)

$1.83

Free cash flow (fiscal 2025)

$1.33B

Edwards Lifesciences Corp files with the U.S. Securities and Exchange Commission under CIK 0001099800, classified as Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.